| |
| |
|
| Insider
Information: |
Vagelos P Roy |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
717,380 |
|
|
Indirect Shares
|
1,322,453 |
|
|
| Direct
Value |
$320,033,609 |
|
|
|
Indirect Value
|
$173,832,193 |
|
|
| Total
Shares |
2,039,833 |
|
|
| Total
Value |
$493,865,803 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2023-04-03 |
312,578 |
2023-04-03 |
154,526 |
Premium* |
|
|
Innoviva Inc |
INVA |
Director |
2009-12-23 |
404,802 |
2009-12-23 |
1,167,927 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
266 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2018-11-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
37,209 |
350,240 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2015-11-03 |
4 |
AS |
$580.23 |
$2,312,217 |
D/D |
(3,985) |
351,851 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2015-11-02 |
4 |
AS |
$580.18 |
$7,691,446 |
D/D |
(13,257) |
355,836 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2019-12-12 |
4 |
D |
$377.16 |
$21,050,431 |
D/D |
(55,813) |
356,327 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2006-09-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
13,534 |
359,642 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2009-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
50,384 |
361,251 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2017-08-21 |
4 |
S |
$470.23 |
$11,414,076 |
D/D |
(24,269) |
361,487 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2019-11-22 |
4 |
D |
$358.33 |
$8,595,978 |
D/D |
(23,989) |
362,727 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-25 |
4 |
OE |
$179.13 |
$13,434,750 |
D/D |
75,000 |
366,090 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-02-22 |
4 |
OE |
$270.43 |
$11,493,275 |
D/D |
42,500 |
366,583 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2014-11-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
24,900 |
369,093 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2012-11-23 |
4 |
OE |
$19.43 |
$6,071,875 |
D/D |
312,500 |
369,446 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2006-06-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
17,309 |
373,176 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2013-09-18 |
4 |
OE |
$13.00 |
$4,062,500 |
D/D |
312,500 |
378,259 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2017-08-18 |
4 |
S |
$470.15 |
$1,363,435 |
D/D |
(2,900) |
385,756 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2019-11-22 |
4 |
OE |
$21.25 |
$980,433 |
D/D |
46,138 |
386,716 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2018-08-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,500 |
387,449 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2019-05-24 |
4 |
D |
$313.64 |
$25,142,637 |
D/D |
(80,164) |
388,505 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2017-08-17 |
4 |
S |
$470.00 |
$613,350 |
D/D |
(1,305) |
388,656 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2017-08-16 |
4 |
S |
$470.17 |
$5,165,288 |
D/D |
(10,986) |
389,961 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2006-03-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,065 |
390,485 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2014-08-26 |
4 |
D |
$351.62 |
$56,820,737 |
D/D |
(161,597) |
390,852 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-03-14 |
4 |
OE |
$179.13 |
$13,434,750 |
D/D |
75,000 |
393,669 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2017-12-11 |
4 |
D |
$383.29 |
$32,067,958 |
D/D |
(83,665) |
399,847 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2018-06-21 |
4 |
AS |
$323.97 |
$24,495,410 |
D/D |
(74,710) |
399,847 |
0 |
- |
|
266 Records found
|
|
Page 9 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
